RWD Innovation Graticule positions itself as a real-world data network operator accelerating medical innovation through strategic use of RWD, presenting a strong value proposition for health system partners seeking evidence generation and market access optimization.

Global Network With a growing set of health system, business, legal, and technology relationships, Graticule offers longitudinal patient journey data across US and ex-US markets, enabling scalable, representative data access for commercial research projects.

Strategic Partnerships Historical collaborations with Life Image (GLIMPS), Deep 6 AI, and executive-level hires indicate a focus on expanding data capabilities and research applications, suggesting cross-sell opportunities in data licensing, advisory services, and alliance-led expansions in EU operations.

Awards & Recognition Finalist in the 2024 AMIA/HL7 FHIR awards signals credibility in interoperability and innovative use of FHIR-based data, which can be leveraged to accelerate conversations with prospective health systems and life sciences customers seeking standards-aligned solutions.

Growth & Funding Signals Revenue range of 1–10 million and a lean employee base imply potential for scalable partnerships, managed services, and incremental value through expanded data access, licensing, and expanded global data sourcing for both US and international markets.